SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

From a price-performance perspective, BMY has fetched slightly better returns than AMGN in the past six months. Shares of AMGN have gained 13.5%, while those of BMY have gained 13.9%. The industry has ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...

If you take Zepbound, a doctor or another healthcare professional will likely give you the first dose in their office. Then, they’ll show you or someone else how to inject Zepbound at home. Here’s how ...

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP. The study, published Thursday, found that the out-of-pocket cost of ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

On a review of current liquidity and financial conditions, the Reserve Bank of India (RBI) on Tuesday (December 23, 2025) announced to conduct Open Market Operation (OMO) purchase auctions of ...

The Federal Reserve (Fed) is set to inject about $6.8 billion into financial markets on December 22, 2025, via repurchase agreements. This marks its first liquidity operation of this kind since 2020, ...

WASHINGTON, Dec ‌18 (Reuters) - Americans enrolled in Medicare will ‌pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol Myers Squibb's blood thinner Eliquis and Merck ...

ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...